Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #711

    The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications https://ashpublications.org/blood/article-abstract/136/20/2334/461276/The-JAK-STAT-pathway-regulates-CD38-on-myeloma?redirectedFrom=fulltext

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #712

      Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma https://www.mdpi.com/1422-0067/21/22/8553/htm

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #713

        lol, how to make a headline that will
        get people to click on your article, "Janssen combines Darzalex with COVID drug in new multiple myeloma submission" https://pharmaphorum.com/news/janssen-combines-darzalex-with-covid-drug-in-new-multiple-myeloma-submission/

        1 Reply Last reply
        0
        • D Offline
          D Offline
          DevOp
          wrote on sidst redigeret af
          #714

          Seems data from the NSCLC expansion is unlikely to be presented already, but aren't they compelled to present the data either at a conference or at least one of the medical journals? And if that's the case, I guess ASH would be no good as it's only hematology - but which conference would be a good guess for results then - something in May/June?

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #715

            One of these 😉 https://waset.org/oncology-conferences

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #716

              Asco would be a good guess

              1 Reply Last reply
              0
              • D Offline
                D Offline
                DevOp
                wrote on sidst redigeret af
                #717

                thx, Bulder - that's a pretty comprehensive list :-
                )

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #718

                  Reminder: https://events.bizzabo.com/GenmabCMD

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #719

                    Siden er nede. Help ....

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #720

                      nice timing:

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #721

                        A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL https://clinicaltrials.gov/ct2/show/NCT04628494?term=NCT04628494&draw=2&rank=1

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #722

                          LYRA / Dara-CyBorD completed https://clinicaltrials.gov/ct2/history/NCT02951819?A=25&B=26&C=merged#StudyPageTop

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #723

                            another Dara label extension to follow shortly - Positive recommendations on extensions of indications Name of medicine Kyprolis INN carfilzomib
                            Marketing-authorisation holder Amgen Europe B.V. More information Kyprolis: Pending EC decision (Extension of existing indication to include combination of Kyprolis with daratumumab and dexamethasone)

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #724

                              Dejligt med live billeder 🙂

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #725

                                Epco er voldsomt imponerende 🙂

                                1 Reply Last reply
                                0
                                • A Offline
                                  A Offline
                                  AaBforever
                                  wrote on sidst redigeret af
                                  #726

                                  Kursen reagerer let negativ.

                                  1 Reply Last reply
                                  0
                                  • A Offline
                                    A Offline
                                    AaBforever
                                    wrote on sidst redigeret af
                                    #727

                                    JvdW må op i tempo;-)

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #728

                                      GEN1046 er åbentlyst til mere end NSCLC. Flere data very soon.

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #729

                                        DR5xDR5 næste år.

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #730

                                          Epco tror de meget på er best in class. Sc version er tillige vigtigt kommercielt. ASH bliver interessant igen i år.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger